Retinoid suppression of ventricular muscle cell hypertrophy
US5767155A · kind A · utility
3Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 1996 |
| Grant date | Jun 16, 1998 |
| Priority date | — |
| Expiry date | Jul 22, 2016 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB01D29/661
- WIPO fieldChemical engineering
- WIPO sectorChemistry
Abstract
A method of suppressing ventricular muscle cell hypertrophy induced by an .alpha..sub.1 -adrenergic agonist or endothelin, by providing an effective amount of a retinoic acid compound. Also provided are methods for identifying compounds which suppress ventricular muscle cell hypertrophy, compounds which inhibit the retinoic acid suppression of ventricular muscle cell hypertrophy, and therapeutic methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.